Name: Directory of Approved Biopharmaceutical Products (Pharmaceutical Science s) (en Inglés)
Price: 77550.00 CLP
Availability: InStock
Author: Stefania Spada; Gary Walsh
ISBN: 9780367393960

portada Directory of Approved Biopharmaceutical Products (Pharmaceutical Science s) (en Inglés)

Formato

Libro Físico

Editorial

Crc Press

Autor

Stefania Spada; Gary Walsh

Idioma

Inglés

N° páginas

336

Encuadernación

Tapa Blanda

ISBN13

9780367393960

N° edición

Directory of Approved Biopharmaceutical Products (Pharmaceutical Science s) (en Inglés)

Stefania Spada; Gary Walsh (Autor) · Crc Press · Tapa Blanda

Libro Nuevo

$ 77.550

$ 107.710

Ahorras: $ 30.160

28% descuento

Envío normal

Origen: Estados Unidos (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Miércoles 26 de Junio y el Miércoles 10 de Julio.

Lo recibirás en cualquier lugar de Chile entre 1 y 3 días hábiles luego del envío.

Reseña del libro "Directory of Approved Biopharmaceutical Products (Pharmaceutical Science s) (en Inglés)"

Biopharmaceuticals, the term for genetically engineered therapeutic proteins, monoclonal antibodies, and nucleic acid-based products, have become an increasing part of the pharmaceutical armament. While this category of drugs accounts for approximately 25% of all new drugs coming to market, very few references exist that review these commercially available products. Until now, accessing data on the list of currently approved biopharmaceuticals has been laborious and patchy. Directory of Approved Biopharmaceutical Products brings together key information on various aspects of these compounds, presenting a brief summary of each biopharmaceutical currently approved for medical use. Each summary includes the scientific and trade name, year and regions approved, approved indications, manufacturer, marketing right, method of manufacture, scientific overview, and therapeutic properties. Based on information gathered from regulatory agencies and pharmaceutical manufacturers, the book presents the most comprehensive data currently available in a single, convenient volume. This comprehensive and consistent approach will save professionals in the pharmaceutical industry hours spent trawling the literature - and provides a singular resource for future reference.